题名 | SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways |
作者 | |
发表日期 | 2023-08 |
发表期刊 | Molecular carcinogenesis 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Journal Article |
关键词 | Raf/ERK1/2 pathway SBK1 apoptosis cervical cancer proliferation |
其他关键词 | LIPID-METABOLISM ; MAPK ; BIOMARKERS ; LNCRNA ; GENES |
摘要 | SH3 domain-binding kinase 1 (SBK1), is a member of the serine/threonine protein kinases family, and was confirmed to be upregulated in cervical cancer in our previous study. Nonetheless, the role of SBK1 in regulating cancer occurrence and development is unclear. In this study, the stable SBK1-knockdown and -overexpressed cell models were constructed by plasmid transfection technology. Cell viability and growth were assessed through CCK-8, colony formation, and BrdU methods. Cell cycle and apoptosis were analyzed by flow cytometry. The JC-1 staining assay was used to explore mitochondrial membrane potential. The scratch and Transwell assays were used to evaluate the cell metastatic ability. The nude mice models were utilized to explore the SBK1 expression affecting tumor growth in vivo. Our research indicated a high expression of SBK1 both in tissues and cells of cervical cancer. The proliferative, migratory, as well as invasive capacities of cervical cancer cells, were suppressed, and apoptosis was enhanced after SBK1 silence, whereas SBK1 upregulation led to opposite results. In addition, Wnt/β-catenin and Raf/ERK1/2 pathways were activated by SBK1 upregulation. Furthermore, downregulation of c-Raf or β-catenin, reversed the proliferation promotion and apoptosis inhibition effects in SBK1-overexpressed cells. The same results were observed with the use of the specific Raf inhibitor. SBK1 overexpression also contributed to tumor growth in vivo. Overall, SBK1 played a vital role in cervical tumorigenesis via activating the Wnt/β-catenin and Raf/ERK1/2 pathways. |
资助项目 | Key Projects of Wenzhou Science and Technology Bureau[ZY2022012];Zhejiang Key Laboratory of Traditional Chinese Medicine for Diagnosis and Treatment of Gynecological Cancers[2022-11] |
出版者 | WILEY |
ISSN | 0899-1987 |
EISSN | 1098-2744 |
卷号 | 62期号:8页码:1147-1162 |
DOI | 10.1002/mc.23552 |
页数 | 16 |
WOS类目 | Biochemistry & Molecular Biology ; Oncology |
WOS研究方向 | Biochemistry & Molecular Biology ; Oncology |
WOS记录号 | WOS:000979574900001 |
收录类别 | PUBMED ; SCIE ; SCOPUS |
在线发表日期 | 2023-05 |
URL | 查看原文 |
PubMed ID | 37132991 |
SCOPUSEID | 2-s2.0-85158110644 |
通讯作者地址 | [Zhu, Xueqiong]Department of Obstetrics and Gynecology,The Second Affiliated Hospital of Wenzhou Medical University,No.109 Xueyuan Xi Rd, Zhejiang,Wenzhou,325027,China |
Scopus学科分类 | Molecular Biology;Cancer Research |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/175224 |
专题 | 第二临床医学院、附属第二医院、育英儿童医院 附属第二医院 第一临床医学院(信息与工程学院)、附属第一医院_妇产科学 |
通讯作者 | Zhu, Xueqiong |
作者单位 | 1.Department of Obstetrics and Gynecology,The Second Affiliated Hospital of Wenzhou Medical University,Zhejiang,Wenzhou,China; 2.Department of Obstetrics and Gynecology,Taizhou Women and Children's Hospital of Wenzhou Medical University,Zhejiang,Taizhou,China |
第一作者单位 | 第二临床医学院,附属第二医院、育英儿童医院; 附属第二医院; 妇产科 |
通讯作者单位 | 第二临床医学院,附属第二医院、育英儿童医院; 附属第二医院; 妇产科 |
第一作者的第一单位 | 第二临床医学院,附属第二医院、育英儿童医院 |
推荐引用方式 GB/T 7714 | Chen, Xin,Sun, Zhengwei,Zhou, Shengjie,et al. SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways[J]. Molecular carcinogenesis,2023,62(8):1147-1162. |
APA | Chen, Xin., Sun, Zhengwei., Zhou, Shengjie., Jiang, Wenxiao., Li, Jieyi., ... & Zhu, Xueqiong. (2023). SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways. Molecular carcinogenesis, 62(8), 1147-1162. |
MLA | Chen, Xin,et al."SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways".Molecular carcinogenesis 62.8(2023):1147-1162. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论